8 Companies Claim CVS Health Overcharged for Prescription Drugs
Emergency Use Authorization Granted for GSK-Vir COVID-19 Antibody
Prescribers Switch to Remdesivir for COVID-19 Treatment
J&J’s Biologic Therapy Stelara Helps Crohn’s, Ulcerative Colitis
Japan Grants AstraZeneca’s COVID-19 Vaccine Emergency Use
Moderna’s mRNA COVID-19 Vaccine 100% Effective in Adolescents
FDA Approves Janssen’s Targeted Non-Small Cell Lung Cancer Therapy
GSK-Medicago COVID-19 Vaccine Elicits High Antibody Responses
Thermo Fisher, UCSF Boost Manufacturing of Cell-Based Therapies
GSK, Sanofi COVID-19 Vaccine Elicits Strong Antibody Response
Pharmaceutical Supply Chain Cybersecurity Risk Tops $31M Annually
FDA Guidance Addresses Master Protocols for COVID-19 Drugs
Biogen’s XLRP Gene Therapy Fails in Phase 2/3 Clinical Trial
Abbott’s Navitor for Severe Aortic Stenosis Receives CE Mark
Merck’s Keytruda Helps Patients with High-Risk Breast Cancer
Top mRNA COVID-19 Vaccines 94% Effective, New CDC Data Shows
Moderna Provides 25M Doses of COVID-19 Vaccine to Australia
Biogen, Capsigen Create AAV Capsids to Deliver Gene Therapies
Eli Lilly Taps saRNA Research Tech from MiNA for Drug Discovery
Eli Lilly Takes on Digital Diabetes Care Management
EMA Assesses Blood Clots, Other Side Effects of COVID-19 Vaccines
Pfizer, BioNTech Seek Full FDA Approval for COVID-19 Vaccine
Pfizer COVID-19 Vaccine Can be Used in Adolescents, FDA Says
Out-of-Pocket Costs for Brand-Name Medications Increased 15%
NHS Rolls Out 3D Imaging Technology for Heart Disease Diagnosis
MedRhythm Begins Trial to Study Digital Therapeutics for Stroke
Biden Administration Backs Waiver of COVID-19 Intellectual Property
CVS Caremark Prescription Drug Trend Rose to 2.9% in 2020
CVS Goes to Workplace Vaccination Sites to Boost Access
Gavi Secures 500M Doses of Moderna’s COVID-19 Vaccine for COVAX
FDA Greenlights AstraZeneca’s Farxiga for Chronic Kidney Disease
Moderna Increases Global 2022 COVID-19 Vaccine Capacity to 3B
Northwell, Pear Therapeutics Provide New Opioid Treatment Options
Pfizer Acquires Amplyx to Grow Anti-Infective Therapies Pipeline